528 related articles for article (PubMed ID: 31986408)
1. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
2. Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-up.
Markićević M; Džodić R; Buta M; Kanjer K; Mandušić V; Nešković-Konstantinović Z; Nikolić-Vukosavljević D
Int J Med Sci; 2014; 11(7):663-73. PubMed ID: 24843314
[TBL] [Abstract][Full Text] [Related]
3. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
4. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.
Qu Q; Mao Y; Xiao G; Fei X; Wang J; Zhang Y; Liu J; Cheng G; Chen X; Wang J; Shen K
Tumour Biol; 2015 Jul; 36(7):5415-23. PubMed ID: 25687182
[TBL] [Abstract][Full Text] [Related]
5. Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
Liu Y; Li M; Fang Z; Gao S; Cheng W; Duan Y; Wang X; Feng J; Yu T; Zhang J; Wang T; Hu A; Zhang H; Rong Z; Shakila SS; Shang Y; Kong F; Liu J; Li Y; Ma F
Cancer Immunol Immunother; 2024 May; 73(7):117. PubMed ID: 38713229
[TBL] [Abstract][Full Text] [Related]
6. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
Demir H; Dulgar O; Gulle BT; Turna H; Ilvan S
Bosn J Basic Med Sci; 2018 Nov; 18(4):313-319. PubMed ID: 29924962
[TBL] [Abstract][Full Text] [Related]
8. TLR5: A prognostic and monitoring indicator for triple-negative breast cancer.
Shi D; Zhao S; Jiang W; Zhang C; Liang T; Hou G
Cell Death Dis; 2019 Dec; 10(12):954. PubMed ID: 31852883
[TBL] [Abstract][Full Text] [Related]
9. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
10. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
[TBL] [Abstract][Full Text] [Related]
11. ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.
Lin Y; Li C; Xiong W; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Nov; 12(11):1042. PubMed ID: 34725332
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
Sheng J; Xue X; Jiang K
Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
[TBL] [Abstract][Full Text] [Related]
13. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
14. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
16. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
[TBL] [Abstract][Full Text] [Related]
17. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
Liu F; Zhuang L; Wu R; Li D
J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
[TBL] [Abstract][Full Text] [Related]
18.
Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
[No Abstract] [Full Text] [Related]
19. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
[TBL] [Abstract][Full Text] [Related]
20. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
